Keeping Current

Keeping Current

Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer

Informações:

Añadir a la estante
Escucha
Escucha
Escucha

Sinopsis

Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer? Credit available for this activity expires: 3/19/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu

Show more